期刊文献+

儿童朗格汉斯细胞组织细胞增生症13例临床特征分析 被引量:1

Analysis of Clinical Features of 13 Cases of Children with Langerhans' Cell Hyperplastic Disease
下载PDF
导出
摘要 目的探讨儿童朗格汉斯细胞组织细胞增生症(LCH)的临床特点,提高诊治水平。方法方便2013年1月—2017年6月在该院确诊的13例朗格汉斯细胞组织细胞增生症患儿进行回顾性分析。结果单系统组LCH 6例,多系统组LCH 7例,两组的性别构成比差异无统计学意义,多系统组发病年龄显著小于单系统组。儿童多累及骨(61.5%)、皮肤(53.8%)、肺(46.2%)、肝(46.2%)、脾(23.1%)、耳(30.8%)等。结论 LCH临床表现多样,病情轻重不一,明确诊断规范治疗可改善预后。 Objective To study the clinical features of Langerhans'cell Hyperplastic disease and improve the diagnosis and treatment level.Methods 13 cases of children with LCH diagnosed in our hospital from January 2013 to June 2017 were convenient analyzed.Results There were 6 cases in the single system group and 7 cases in the multiple systems group,and the difference in the gender ratio between the two groups was not statistically significant,and the onset age in the multiple systems group was younger than that in the single system group,and the children are mainly involved in bone(61.5%),skin(53.8%),lung(46.2%),liver(46.2%),spleen(23.1%)and era(30.8%).Conclusion The clinical manifestations of LCH are multiple,and the severity of the disease is different,and the prognosis can be improved after clearing the diagnosis standards.
作者 许春华 安美玉 陈芬 姚彤 罗新辉 XU Chun-hu;AN Mei-yu;CHEN Fen;YAO Tong;LUO Xin-hui(Department of Pediatrics,Xinjiang Uygur Autonomous People's Hospital,Urumqi,Xinjiang,830001 China)
出处 《中外医疗》 2017年第35期33-34,56,共3页 China & Foreign Medical Treatment
关键词 朗格汉斯细胞组织细胞增生症 儿童 骨骼 皮肤 LCH Children Bone Skin
  • 相关文献

参考文献3

二级参考文献31

  • 1王宏胜,李军,马伴吟,高怡瑾,陆凤娟,钱晓文.改良DAL-HX83/90方案治疗儿童郎格罕细胞组织细胞增生症24例疗效观察[J].中国小儿血液与肿瘤杂志,2007,12(2):60-63. 被引量:12
  • 2Histiocyte Society. Langerhans cell histiocytosis evaluation and treatment guideline. April,2009. Availabele from : http ://www. heamatologie-amc, nl/odijk/bijlagen. 被引量:1
  • 3Minkov M. Multisystem Langerhans cell histiocytosis in children: current treatment and future directions. Paediatr Drugs, 2011,13 : 75 -86. 被引量:1
  • 4Gadner I-I, Grois N, Arico M, et al. A randomized trial of treatment for multisystem Langerhans' cell histioeytosis. J Pediatr, 2001, 138:728-734. 被引量:1
  • 5treatment ot multisystem Langerhans cell histiocytosis : important prognostic indicator. Med Pediatr Oncol, 2002,39:581- 585. 被引量:1
  • 6Bernard F, Thomas C, Bertrand Y,et al. Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside corobined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction. Eur J Cancer, 2005,41:2682-2689. 被引量:1
  • 7Steiner M, Matthes-Martin S, Attarbaschi A, et al. Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced- intensity conditioning. Bone Marrow Transplant, 2005,36: 215- 225. 被引量:1
  • 8Egeler RM, de Kraker J, Vo6te PA. Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction: experience at a single institution. Med Pediatr Oncol, 1993,21: 265-270. 被引量:1
  • 9Stine KC, Saylors RL, Williams LL, et al. 2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients. Med Pediatr Oncol, 1997,29: 288-292. 被引量:1
  • 10Stine KC, Saylors RL, Saccente S, et al. Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis. Pediatr Blood Cancer, 2004,43:81-84. 被引量:1

共引文献85

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部